ScienceDex / Researcher record
Sciavolino, Frank
- Thetis Pharmaceuticals, LLC (no department on record)
From the FY2019 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2019
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2017 | $205,992 | 1 | #31,267 |
| 2018 | $1,679,504 | 3 | #3,668 |
| 2019 | $2,357,766 | 4 | #2,432 |
| 2020 | $498,366 | 1 | #10,216 |
| 2021 | $299,561 | 1 | #32,918 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20171 record
- FY20183 records
- FY2019 · selected4 records
- FY20201 record
- FY20211 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2021Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2019 award records by amount
NIH award records listing Sciavolino, Frank as a PI. Multi-PI records show the full award amount for context.
- 4R44DK116463-02R44Contact PIDevelopment of TP-252 for the Maintenance of Remission in Pediatric Ulcerative Colitis Patients$1.2Maward amount
- 5R44DK116460-03R44Contact PIDevelopment of TP-317 for the Induction and Maintenance of Remission in Ulcerative Colitis Patients$572Kaward amount
- 1R44DK121612-01A1R44Contact PIDevelopment of TP-352 for the Treatment of Pediatric Non-alcoholic Steatohepatitis$295.6Kaward amount
- 1R43AI145455-01R43Contact PIDevelopment of TP-317 for the Treatment of Eosinophilic Esophagitis$293.7Kaward amount
Award organization
Organizations that administered FY2019 awards listing Sciavolino, Frank as a PI.
FY2019 award administered by Thetis Pharmaceuticals, LLC (CT).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardThetis Pharmaceuticals, LLC
- 2018$500K Cumulative Funding
- 2018$1M Cumulative Funding
- 2018Entered Top 50% NationallyRanked #3668
- 2018Entered Top 25% NationallyRanked #3668
- 2019$2M Cumulative Funding
- 2021$5M Cumulative Funding